Akkermansia Muciniphila Test

If you have ever wondered whether the bacteria living in your gut are working with you or against you, this is one of the most revealing single microbes to check. Akkermansia muciniphila is a bacterium that lives in the mucus layer of your intestine, and how much of it you carry has been tied to body weight, blood sugar control, inflammation, liver health, and even how well some cancer treatments work.

This is not a blood test and not part of any standard panel. It is a stool measurement of a specific gut species, reported as a relative abundance. The level you carry is shaped by your diet, medications, and the health of your gut lining, and it can shift meaningfully over weeks to months.

What Akkermansia Actually Does

Akkermansia muciniphila (often shortened to Akk) is a mucus-eating bacterium that lives in the protective gel layer coating your intestine. It uses the mucus itself as food and, in return, helps keep that layer thick and intact. A thicker, healthier mucus layer means fewer bacterial fragments and inflammatory triggers leak into your bloodstream.

In healthy adults, Akk typically makes up about 1 to 4 percent of the gut microbiota. It produces short-chain fatty acids (small molecules your cells use for energy and signaling), supports tight junctions (the seals between gut-lining cells), and influences immune tone. These roles place Akk at the intersection of metabolism, inflammation, and gut barrier integrity.

Metabolic Health and Obesity

Of every health link Akk has, the metabolic one has the most human data behind it. Higher abundance tracks with leaner bodies, lower fasting glucose, healthier fat distribution, and better insulin sensitivity. Lower abundance shows up in obesity, metabolic syndrome, and type 2 diabetes.

In a diet intervention of 49 overweight and obese adults, people with higher baseline Akk had a healthier starting metabolic profile and improved more on insulin sensitivity and other cardiometabolic markers after calorie restriction. In a proof-of-concept randomized trial of 40 overweight and obese insulin-resistant adults, three months of pasteurized Akk supplementation improved insulin sensitivity by about 29 percent versus placebo, along with lower insulin and total cholesterol.

A nuance worth knowing: in very severe obesity, Akk is lower, and the rebound after bariatric surgery does not cleanly track with metabolic improvement. In other words, Akk is part of the metabolic picture, not the whole thing.

Lean Type 2 Diabetes

Not every person with type 2 diabetes is overweight. In a study of 182 adults, people with lean type 2 diabetes had distinctly lower Akk abundance, and the drop correlated with impaired insulin secretion and altered bile acid handling. If you have unexplained blood sugar trouble despite a healthy weight, a low Akk reading adds a missing piece to the puzzle that routine labs do not capture.

Inflammatory Bowel Disease

Akk is consistently depleted in active ulcerative colitis and Crohn's disease. In a 54-person study of ulcerative colitis, lower abundance tracked with higher inflammation and reduced sulfated mucins (a marker of mucus layer quality). A separate 77-person analysis found the depletion especially pronounced in early-onset Crohn's disease. A longitudinal ulcerative colitis study of 105 patients also found that Akk patterns predicted how soon people relapsed after reaching remission.

Liver and Alcohol-Related Disease

Chronic alcohol intake lowers Akk, and the depletion is tied to leakier gut barriers and more liver inflammation. A systematic review of human and animal evidence found that restoring Akk abundance can improve features of alcohol-related liver disease. In people living with HIV, a 103-person study found lower intestinal Akk in those with fatty liver disease, overweight, or hyperlipidemia, with abundance predicting progression of non-alcoholic fatty liver disease.

Cancer Immunotherapy Response

One of the more striking findings in this literature comes from cancer care. In a metagenomic analysis of 338 advanced non-small-cell lung cancer patients, those with detectable Akk in stool before starting a PD-1 checkpoint inhibitor (a type of immunotherapy) had higher response rates and longer overall survival. The association held independent of PD-L1 expression, antibiotic exposure, and performance status.

There is a twist. Very high abundance (above roughly 4.8 percent), especially in people who had recently taken antibiotics, was linked to worse outcomes. Moderate levels looked best. This is a reminder that more is not always better with Akk.

Reconciling the Counterintuitive Findings

Akk also shows up over-represented in colorectal cancer tissue as part of a four-bacteria panel that discriminated cancer from controls with high accuracy. So is Akk good or bad? The honest answer is that it is a context-dependent marker, not a simple good-bug or bad-bug score. In most settings, especially metabolic, inflammatory, and immunotherapy contexts, adequate but not extreme abundance tracks with better outcomes. In certain disease microenvironments or after antibiotic disruption, the story is less clean. Treat your result as one informative signal within a bigger gut and metabolic picture, not as a verdict.

Reference Ranges

There are no professional guidelines, no universally accepted cutpoints, and no lab-certified normal ranges for Akk. The numbers below come from specific research cohorts using stool metagenomics, reported as relative abundance. They vary by population, diet, and assay method. Use them as orientation, not as targets. Your lab may report different values.

Compare your results within the same lab over time for the most meaningful trend. A single number should never drive a decision. Source: Derosa et al. NSCLC metagenomic cohort, n=338; Dao et al. obesity cohort, n=49; Zhang et al. Chinese healthy controls and IBD, n=180.

When Results Can Be Misleading

Akk abundance is unusually dynamic. Longitudinal sampling in healthy adults shows day-to-day swings, short-term blooms, and strain replacement over weeks. A single reading is a snapshot, not a verdict. Several specific factors can shift the number without reflecting a real change in your underlying gut health.

• Recent antibiotics: broad-spectrum antibiotics can reshape Akk abundance and select for less beneficial strain variants, distorting both the level and its biological meaning.
• Recent diet changes: fibers, polyphenols, and calorie restriction can rapidly raise Akk, while low-FODMAP diets may lower it. A stool sample taken days after a major diet shift may not reflect your usual state.
• Dexamethasone, PPIs, statins, and NSAIDs: these common medications can alter the broader gut microbiome, which may indirectly shift Akk readings even though none of them directly treat the conditions this marker tracks. If you are taking these, interpret single readings cautiously.
• Assay method: qPCR versus shotgun metagenomics can give different numbers for the same stool sample. Trends within a single lab are more meaningful than cross-lab comparisons.

Why One Reading Is Not Enough

Because Akk fluctuates naturally and responds to diet, medication, and gut state, a single measurement tells you less than a trend. Get a baseline, make whatever changes you are going to make (a fiber-rich diet, time off antibiotics, or medication adjustments), then retest in three to six months. After that, annual tracking is reasonable for someone actively managing metabolic or gut health.

Serial readings matter for another reason: they let you test whether a specific change is working for you. If you start a prebiotic fiber, a Mediterranean diet, or metformin, a follow-up reading shows whether your gut ecology actually shifted. Without a trend line, it is too easy to confuse noise for signal.

What To Do If Your Result Is Low

A low Akk reading is not a diagnosis. It is a signal worth investigating alongside other markers. The most useful companion tests are fecal calprotectin (for gut inflammation), a broader stool microbiome profile (to see if other beneficial species are also low), and metabolic labs including fasting insulin, hs-CRP, ALT, and lipids. If your Akk is low and you also see elevated calprotectin, a gastroenterologist is worth involving. If it is low alongside insulin resistance or fatty liver markers, the case for a metabolic workup and targeted lifestyle changes gets stronger.

If your result is very high, especially after recent antibiotic use, the right move is usually to retest in a few months once your gut has stabilized, rather than acting on a single spike. The pattern over time, seen alongside your other labs, is what to trust.